AGED.L vs. BTEE.L
AGED.L (iShares Ageing Population UCITS ETF USD (Acc)) and BTEE.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) are both exchange-traded funds - AGED.L is a Global Equities fund tracking the Stoxx Global Ageing Population Net USD Index, while BTEE.L is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 5 years, AGED.L returned 6.70%/yr vs 6.03%/yr for BTEE.L. A 0.70 correlation means they provide meaningful diversification when combined. AGED.L charges 0.40%/yr vs 0.35%/yr for BTEE.L.
Performance
AGED.L vs. BTEE.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AGED.L achieves a 10.97% return, which is significantly lower than BTEE.L's 15.88% return.
AGED.L
- 1D
- -0.56%
- 1M
- 4.63%
- 6M
- 8.81%
- YTD
- 10.97%
- 1Y
- 24.79%
- 3Y*
- 15.35%
- 5Y*
- 6.70%
- 10Y*
- —
BTEE.L
- 1D
- 0.53%
- 1M
- 8.65%
- 6M
- 14.22%
- YTD
- 15.88%
- 1Y
- 47.91%
- 3Y*
- 16.94%
- 5Y*
- 6.03%
- 10Y*
- —
AGED.L vs. BTEE.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
AGED.L iShares Ageing Population UCITS ETF USD (Acc) | 10.97% | 26.75% | 7.86% | 9.03% | -14.29% | 4.61% | 13.29% | 19.47% | -13.28% |
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 15.88% | 32.76% | -1.61% | 5.72% | -11.87% | -0.47% | 27.48% | 25.64% | -13.61% |
Correlation
The correlation between AGED.L and BTEE.L is 0.64, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.64 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.66 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.69 |
Correlation (All Time) Calculated using the full available price history since Mar 5, 2018 | 0.70 |
The correlation between AGED.L and BTEE.L has been stable across timeframes, ranging from 0.64 to 0.70 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AGED.L vs. BTEE.L — Risk / Return Rank
AGED.L
BTEE.L
AGED.L vs. BTEE.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Ageing Population UCITS ETF USD (Acc) (AGED.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AGED.L | BTEE.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.74 | ||
| Sortino ratioReturn per unit of downside risk | -0.88 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.38 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 2.94 | 6.24 | -3.30 |
| Martin ratioReturn relative to average drawdown | 10.69 | 18.49 | -7.80 |
Loading charts...
Drawdowns
AGED.L vs. BTEE.L - Drawdown Comparison
The maximum AGED.L drawdown since its inception was -40.12%, roughly equal to the maximum BTEE.L drawdown of -38.29%. Use the drawdown chart below to compare losses from any high point for AGED.L and BTEE.L.
Loading charts...
Drawdown Indicators
| AGED.L | BTEE.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.12% | -38.29% | -1.83% |
Max Drawdown (1Y)Largest decline over 1 year | -8.40% | -7.64% | -0.76% |
Max Drawdown (3Y)Largest decline over 3 years | -16.38% | -26.76% | +10.38% |
Max Drawdown (5Y)Largest decline over 5 years | -27.68% | -38.29% | +10.61% |
Current DrawdownCurrent decline from peak | -1.21% | -3.24% | +2.03% |
Average DrawdownAverage peak-to-trough decline | -8.53% | -13.34% | +4.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.31% | 2.58% | -0.27% |
Volatility
AGED.L vs. BTEE.L - Volatility Comparison
The current volatility for iShares Ageing Population UCITS ETF USD (Acc) (AGED.L) is 3.66%, while iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) has a volatility of 5.62%. This indicates that AGED.L experiences smaller price fluctuations and is considered to be less risky than BTEE.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AGED.L | BTEE.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.66% | 5.62% | -1.96% |
Volatility (6M)Calculated over the trailing 6-month period | 12.24% | 15.53% | -3.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.34% | 20.30% | -4.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.77% | 21.19% | -3.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.74% | 22.48% | -4.74% |
AGED.L vs. BTEE.L - Expense Ratio Comparison
AGED.L has a 0.40% expense ratio, which is higher than BTEE.L's 0.35% expense ratio.
Dividends
AGED.L vs. BTEE.L - Dividend Comparison
AGED.L has not paid dividends to shareholders, while BTEE.L's dividend yield for the trailing twelve months is around 0.23%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
AGED.L iShares Ageing Population UCITS ETF USD (Acc) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.23% | 0.37% | 0.46% | 0.39% | 0.44% | 0.25% | 0.17% | 0.14% | 0.07% |
Frequently Asked Questions
AGED.L and BTEE.L have a correlation of 0.64, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, BTEE.L is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
BTEE.L is cheaper with a 0.35% expense ratio, compared with 0.40% for AGED.L.
AGED.L is categorized as Global Equities, while BTEE.L is Health & Biotech Equities. AGED.L tracks Stoxx Global Ageing Population Net USD Index, while BTEE.L tracks NASDAQ Biotechnology TR USD. Their fees differ too: 0.40% for AGED.L and 0.35% for BTEE.L.
Find the right allocation for AGED.L and BTEE.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer